Protherics PLC Notification of Directors' Interests London, UK; Brentwood, TN; 18 December 2006 - Protherics PLC (the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, on 15 December 2006, options over 2p ordinary shares in the Company were granted to the following directors under the terms of the Protherics PLC Long Term Incentive Plan: Name Number of Options Granted Andrew J Heath 215,304 Barry M Riley 119,322 James C Christie 118,644 The options are exercisable between the third and tenth anniversary of the date of grant at a price of 2p per share, subject to the achievement of performance conditions. Following the above grant of options, the above directors hold options over the following number of shares: Andrew J Heath 3,621,900 Barry M Riley 1,456,227 James C Christie 1,253,698 The current issued ordinary share capital of the Company is 261,489,793 shares. | Ends | For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, David Yates +44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange
Protherics PLC announces Director/PDMR Shareholding - 1
| Source: Protherics PLC
Cheshire, UK -- (MARKET WIRE) -- December 18, 2006 --